These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 17472415

  • 1. Ruboxistaurin: LY 333531.
    Drugs R D; 2007; 8(3):193-9. PubMed ID: 17472415
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).
    Sheetz MJ, Aiello LP, Shahri N, Davis MD, Kles KA, Danis RP, Mbdv Study Group.
    Retina; 2011 Jun; 31(6):1053-9. PubMed ID: 21386766
    [Abstract] [Full Text] [Related]

  • 7. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005 Jun; 6(3):178-85. PubMed ID: 15869322
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ruboxistaurin: PKC-beta inhibition for complications of diabetes.
    Danis RP, Sheetz MJ.
    Expert Opin Pharmacother; 2009 Dec; 10(17):2913-25. PubMed ID: 19929710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.
    PKC-DMES Study Group.
    Arch Ophthalmol; 2007 Mar; 125(3):318-24. PubMed ID: 17353401
    [Abstract] [Full Text] [Related]

  • 13. Ruboxistaurin (Eli Lilly).
    Wheeler GD.
    IDrugs; 2003 Feb; 6(2):159-63. PubMed ID: 12789620
    [Abstract] [Full Text] [Related]

  • 14. Roflumilast: APTA 2217, B9302-107, BY 217, BYK 20869.
    Drugs R D; 2004 Feb; 5(3):176-81. PubMed ID: 15139782
    [Abstract] [Full Text] [Related]

  • 15. Ruboxistaurin.
    Taulien CA, Joy SV.
    Drugs Today (Barc); 2006 Sep; 42(9):577-85. PubMed ID: 17028667
    [Abstract] [Full Text] [Related]

  • 16. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
    Drugs R D; 2007 Sep; 8(5):321-34. PubMed ID: 17767397
    [Abstract] [Full Text] [Related]

  • 17. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003 Sep; 17(4):290-5. PubMed ID: 12899647
    [Abstract] [Full Text] [Related]

  • 18. Ruboxistaurin mesilate hydrate for diabetic retinopathy.
    Schwartz SG, Flynn HW, Aiello LP.
    Drugs Today (Barc); 2009 Apr; 45(4):269-74. PubMed ID: 19499092
    [Abstract] [Full Text] [Related]

  • 19. Anidulafungin: ECB, LY 303366, V-echinocandin, VEC, VER 002, VER-02.
    Drugs R D; 2003 Apr; 4(3):167-73. PubMed ID: 12757403
    [Abstract] [Full Text] [Related]

  • 20. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005 Apr; 6(2):120-7. PubMed ID: 15777106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.